We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.
Arch Intern Med. 1997;157:1753-1757
Kerridge I, Lowe M, Seldon M, Enno A, Deveridge S. Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia. Arch Intern Med. 1997;157(15):1753–1757. doi:10.1001/archinte.1997.00440360189020
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.